Latest News | Gland Pharma Reports Rs 192 Cr Profit After Tax in Q3

Get latest articles and stories on Latest News at LatestLY. Gland Pharma on Wednesday said its consolidated Profit After Tax (PAT) stood at Rs 192 crore for the December quarter.

New Delhi, Feb 14 (PTI) Gland Pharma on Wednesday said its consolidated Profit After Tax (PAT) stood at Rs 192 crore for the December quarter.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Also Read | APPSC Group 2 Hall Ticket 2023 Released at psc.ap.gov.in: Admit Card for Group 2 Services Examination Out, Know Steps To Download.

The company's revenue from operations stood at Rs 1,545 crore for the October-December period, up from Rs 938 a year ago.

The results for the quarter under review and the nine months of the current fiscal are not comparable to the earlier periods of the previous year due to the inclusion of Cenexi results, the Hyderabad-based company said.

Also Read | Saraswati Temples in India: From Dakshina Mookambika to Sri Vidya Saraswathi Shaneeshwara, Mandirs Across The Country Dedicated to the Goddess of Knowledge.

On November 29, 2022, the Hyderabad-based drug Contract Development and Manufacturing Company (CDMO) had entered into a put option agreement to acquire Cenexi Group for up to 120 million euros, marking its foray into the international markets.

"In the ex-Cenexi base business, we are happy to keep up with the growth aspirations, and the performance has been encouraging with the introduction of new products and improved volumes of the current basket," Gland Pharma MD and CEO Srinivas Sadu said.

The post-merger integration review is now mostly complete, and the drug firm has identified areas where Cenexi would need investments and significant improvements, he added.

"Our partner order book is healthy, and we have significant opportunities through the signed contracts to play out long-term growth. However, in the near term, we continue to face issues with operational performance, leading us to rebalance our capacity and shift certain products to different lines, which will take time due to regulatory processes," Sadu said.

The company is confident that it will end FY24 on a high note, he added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now